CardioGenesis Corporation (OTC:CGCP) to Hold Q4 2007 Earnings Conference Call March 25

CardioGenesis Corporation (OTC:CGCP) will hold a conference call on Tuesday, March 25 at 12:00 pm to discuss the fourth quarter earnings for 2007.

CardioGenesis is engaged in the design, development and distribution of laser based surgical products and disposable fiber-optic accessories to treat ischemia related to advanced cardiovascular disease through transmyocardial revascularization (TMR) and percutaneous myocardial channeling (PMC).

Laser based heart treatments, TMR and PMC create channels  in the heart muscle and have received the United States Food and Drug Administration (FDA).

A new product pipeline includes port enabled angina relief by using laser (PEARL) Robotic 5.0 and Thoracoscopic 8.0 minimally invasive delivery systems and Phoenix Combination Delivery System.

CardioGenesis Corporation (OTC:CGCP)

To view more Conference Call related events or to post your own events, visit:

http://events.finditt.com/Events_List.aspx?catid=12